2,6-BIS((4R,5R)-4,5-DIHYDRO-4,5-DIPHENYL-2-OXAZOLYL)PYRIDINE, 95%, 1g

2-Methoxyphenylsulfonylethanol, 98.0%, 1g

2,2-Dimethylpent-4-enoic acid, 97.0%, 10g

2-(2-Chloroethoxy)acetic acid, 95.0%, 5g

2-[(6-Ethoxy-pyrimidin-4-ylamino)-methyl]-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

N,N'-Bis[4-di(m-tolyl)aminophenyl]-N,N'-diphenylbenzidine, >98.0%(HPLC), 25g

(2E)-3-(2-ethoxyphenyl)-1-(3-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Methyl Morpholin-2-ylacetate hydrochloride, 97.0%, 1g

5-(Trifluoromethoxy)benzo[d]thiazole-2(3H)-thione, 97%, 1g

Prasugrel, 95.0%, 5g

Raccordement à rotule, 13/2, 100 mm, 10 Pièce(s)

6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine, 95.0%, 10g

2-Methylcinnamic Acid>98.0%(GC)(T)25g